|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 07/22/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
TransPacific Partnership
Sanitary and Phytosanitary Issues
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) Amendment on Weed Resistance
Amendment on GE Crop Field Trials/Compensation Fund
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendment on Farmer Assurance
EPA Regulations on Agricultural Biotechnology
Reauthorization and Implementation of Pesticide Registration Improvement Act
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for 2014
Amendment on GE Salmon Labeling (Senate)
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Labeling of Genetically Engineered Crops
U.S. Government Policy
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendments on GE Food Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
EU Biotechnology Bilateral Discussions
Low-Level Presence Foreign Government Policies
Agricultural Biotechnology Regulatory Reform and Modernization
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Benefits of Ag-Biotech Research and Innovation
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2410/S.1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Regulatory Review of Animal Pharmaceuticals
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), White House Office, Environmental Protection Agency (EPA), Council on Environmental Quality (CEQ), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
O'Mara |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for 2014
Amendment on GE Salmon Labeling (Senate)
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Regulatory Review of Animal Pharmaceuticals
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biofuels
Department of Defense Funding/Application of Advanced Biofuels
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Funding for Biomass Crop Assistance Program
S. 1244/ H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
Energy Basic Research Funding
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Council on Environmental Quality (CEQ), Executive Office of the President (EOP), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Matt |
Carr |
|
|
|
Anna |
Weinstein |
|
|
|
Andrew |
Emmett |
|
|
|
Catharine |
Harris |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
David |
Edwards |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Rina |
Singh |
|
|
|
Derrick |
White |
|
|
|
Tom |
DiLenge |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
Schumaker |
|
|
|
Erick |
Lutt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Intellectual Property International Enforcement
Compulsory Licensing
Patent Reform
Implementation of H.R. 1249: The America Invents Act of 2011
House Judiciary Committee Discussion Draft
H.R. 2024: End Anonymous Patents Act
H.R. 845: The SHIELD Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 866: Patent Quality Improvement Act of 2013
DNA Patenting and Licensing
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Health Regulatory Agency Review of Patents
Brazil
Colombia
Asia Pacific Economic Cooperation Forum
Intellectual Property Issues
Drug Patent Settlements
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Fritts |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) Amendment on Weed Resistance
Amendment on GE Crop Field Trials/Compensation Fund
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendment on Farmer Assurance
Genetically Engineered (GE) Animals
Labeling
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for 2014
Amendment on GE Salmon Labeling (Senate)
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Labeling of Genetically Engineered Crops
U.S. Government Policy
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendments on GE Food Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Drug Safety and Review
Supply Chain Integrity
Pharmacy Compounding
HR. 1919: The Safeguarding Americas Pharmaceuticals Act
S. 957: Drug Supply Chain Security Act
S. 959: Pharmaceutical Compounding Quality Act
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), White House Office, Council on Environmental Quality (CEQ), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Kelly |
Cappio |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Phyllis |
Arthur |
|
|
|
Brent |
DelMonte |
|
|
|
Tom |
DiLlenge |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Energy Basic Research Funding
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
Biofuels
Department of Defense Funding/Application of Advanced Biofuels
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 2397: Department of Defense Appropriations Act for FY 2014
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendments on Renewable Fuel Standard
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Renewable Chemicals/Bio-based Products
New Production Tax Credit for Renewable Chemicals
Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
S. 1267: Qualifying Renewable Chemical Production Tax Credit Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
S. 696: The Safe Chemicals Act
Biomass Programs
Reauthorization/Funding of Biomass Crop Assistance Program
H.R. 2410/S 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Council on Environmental Quality (CEQ), Executive Office of the President (EOP), Natl Security Council (NSC), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), Treasury - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for 2014
Amendment on GE Salmon Labeling (Senate)
S. 622: Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Labeling of Genetically Engineered Crops
U.S. Government Policy
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendments on GE Food Labeling
S.1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), White House Office, U.S. Trade Representative (USTR), Executive Office of the President (EOP), Council on Environmental Quality (CEQ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Energy Basic Research Funding
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
Biofuels
Department of Defense Funding/Application of Advanced Biofuels
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 2397: Department of Defense Appropriations Act for FY 2014
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Amendments on Renewable Fuel Standard
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Renewable Chemicals/Bio-based Products
New Production Tax Credit for Renewable Chemicals
Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
S. 1267: Qualifying Renewable Chemical Production Tax Credit Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
S. 696: The Safe Chemicals Act
Biomass Programs
Reauthorization/Funding of Biomass Crop Assistance Program
H.R. 2410/S 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Council on Environmental Quality (CEQ), Executive Office of the President (EOP), Natl Security Council (NSC), Natl Economic Council (NEC), Office of Science & Technology Policy (OSTP), Treasury - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
DelMonte |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Biosimilars
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Colombia Biologics Regulations
Mexico Biologics Regulations
Naming
Health Regulatory Agency Review of Patents
Brazil
Colombia
Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Vaccine Access/Financing
Adult Immunization (Senate Discussion Draft)
Tax on Seasonal Influenza Vaccine
H.R. 425/S.391: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines
340B Drug Pricing Program
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
HRSA Implementation of Program Changes
Drug Safety and Review
Supply Chain Integrity
Pharmacy Compounding
HR. 1919: The Safeguarding Americas Pharmaceuticals Act
S. 957: Drug Supply Chain Security Act
S. 959: Pharmaceutical Compounding Quality Act
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Independent Payment Advisory Board
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
Asia Pacific Economic Cooperation Forum
Intellectual Property Issues
Biologics Regulations
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Regulatory Harmonization
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Regulatory Transparency
Orphan Drug Tax Credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Andrew |
Emmett |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Joseph |
Damond |
|
|
|
Lila |
Feisee |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Tracey |
LaTurner |
|
|
|
Phyllis |
Arthur |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
Del Monte |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS), Natl Economic Council (NEC), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
Laurel |
Todd |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
Del Monte |
|
|
|
Jeanne |
Haggerty |
|
|
|
Derrick |
White |
|
|
|
Catharine |
Harris |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Reform of SEC Regulation D
Implementation of H.R. 3606: Jumpstart Our Business Start-ups (JOBS) Act
Capital Formation Investment Incentives
H.R. 6599/S.3595: High Technology Small Business Research Incentives Act
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
Expansion of Exemption Under SEC Regulation A
H.R. 701: To amend a provision of the Securities Act of 1933 directing the Securities and Exchange Commission to
add a particular class of securities to those exempted under such Act to provide a deadline for such action.
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
Fostering Innovation Act (Rep. Fitzpatrick Discussion Draft)
Market Structure Reform for Small Companies
XBRL Exemption for Small Public Companies
Sarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564: The Audit Integrity and Job Protection Act
Stock Exchange Tick Size
H.R. 1952: The Spread Pricing Liquidity Act
Tick Size Flexibility Act (Rep. Duffy Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Office of Science & Technology Policy (OSTP), Natl Economic Council (NEC), White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Weinstein |
|
|
|
Charles |
Fritts |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Charles |
Crain |
|
|
|
Brent |
Del Monte |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels
Production Tax Credit Extension
Tax Reform
Renewable Chemicals/Bio-based Products
Expansion of Advanced Manufacturing Investment Tax Credit to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
S. 1267: Qualifying Renewable Chemical Production Tax Credit Act of 2013
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
Vaccine Access/Financing
Tax on Seasonal Influenza Vaccine
H.R. 425/S.391: A Bill To Amend the Internal Revenue Code of 1986 to Include Vaccines Against Seasonal Influenza Within the Definition of Taxable Vaccines
Capital Formation Investment Incentives
H.R. 6599/S.3595: High Technology Small Business Research Incentives Act
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
Research & Development Tax Credit Extension
Orphan Drug Tax Credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Council on Environmental Quality (CEQ), Executive Office of the President (EOP), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Alan |
Einsenberg |
|
|
|
Derrick |
White |
|
|
|
Brent |
Del Monte |
|
|
|
Dana |
O'Brien |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
Schumaker |
|
|
|
Charles |
Crain |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Intellectual Property International Enforcement
Compulsory Licensing
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
EU Biotechnology Bilateral Discussions,
Low-Level Presence Foreign Government Policies
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency
Sanitary and Phytosanitary Issues
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
Intellectual Property Issues
Regulatory Harmonization
Asia Pacific Economic Cooperation Forum
Intellectual Property Issues
Biologics Regulations
Biosimilars
Colombia Biologics Regulations
Mexico Biologics Regulations
Naming
Health Regulatory Agency Review of Patents
Brazil
Colombia
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), White House Office, Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Lila |
Feisee |
|
|
|
Joseph |
Damond |
|
|
|
Jeanne |
Haggerty |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
O'Mara |
|
|
|
Cathleen |
Enright |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
|
. |
|
|
||
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
SCI |
|
|
|
|
|
|
|
|
CAW |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |